7 Results for "

dolasetron

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "dolasetron" in MCE Product Catalog:

製品番号: HY-B0750
CAS 番号: 115956-12-2
別名: MDL-73147
Target:  

5-HT Receptor

研究分野:  

Cancer

Dolasetron (MDL-73147) is a serotonin 5-HT3 receptor antagonist. Dolasetron acts as an antiemetics agent and can be used for the research of chemotherapy-induced nausea and vomiting in cancer .
製品番号: HY-B0750B
CAS 番号: 878143-33-0
別名: MDL-73147EF hydrate
Target:  

5-HT Receptor

研究分野:  

Cancer

Dolasetron Mesylate hydrate (MDL-73147EF hydrate) is a serotonin 5-HT3 receptor antagonist used to treat nausea and vomiting following chemotherapy .
製品番号: HY-B0750A
CAS 番号: 115956-13-3
別名: MDL-73147EF
Target:  

5-HT Receptor

研究分野:  

Cancer

Dolasetron Mesylate (MDL-73147EF) is a serotonin 5-HT3 receptor antagonist used to treat nausea and vomiting following chemotherapy .
製品番号: HY-B0750BR
CAS 番号: 878143-33-0
別名: MDL-73147EF hydrate (Standard)
研究分野:  

Cancer

Dolasetron Mesylate hydrate (MDL-73147EF hydrate) (Standard) is the analytical standard of Dolasetron Mesylate hydrate (HY-B0750B). This product is intended for research and analytical applications. Dolasetron Mesylate hydrate is a serotonin 5-HT3 receptor antagonist used to treat nausea and vomiting following chemotherapy .
製品番号: HY-B0750S
別名: MDL-73147-d4
Dolasetron (MDL-73147)-d4 is deuterium labeled Dolasetron (HY-B0750). Dolasetron is a serotonin 5-HT3 receptor antagonist. Dolasetron acts as an antiemetics agent and can be used for the research of chemotherapy-induced nausea and vomiting in cancer .
製品番号: HY-B0750S1
別名: MDL-73147-d5
Dolasetron (MDL-73147)-d5 is deuterated labeled Dolasetron (HY-B0750). Dolasetron is a serotonin 5-HT3 receptor antagonist. Dolasetron acts as an antiemetics agent and can be used for the research of chemotherapy-induced nausea and vomiting in cancer .
製品番号: HY-133086
CAS 番号: 127951-99-9
Target:  

5-HT Receptor nAChR

研究分野:  

Neurological Disease Cancer

Hydrodolasetron is a metabolite of Dolasetron (HY-B0750). Hydrodolasetron is more potent than Dolasetron in inhibiting nAChR. Hydrodolasetron is a 5-HT(3A)R blocker with an IC50 of 0.29 nM. Hydrodolasetron has antiemetic activity .